4.8 Article

Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: Mineralization and its effect on tumor targetability in vivo

期刊

JOURNAL OF CONTROLLED RELEASE
卷 168, 期 2, 页码 105-114

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2013.02.022

关键词

Mineralization; Hyaluronic acid; Nanoparticles; Doxorubicin; Stability

资金

  1. MEST [20090081876, 20100027955, 2012012827]
  2. Samsung Advanced Institute of Technology
  3. National Research Council of Science & Technology (NST), Republic of Korea [2E23730] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  4. National Research Foundation of Korea [2009-0081876] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

The in vivo stability and tumor targetability of self-assembled polymeric nanoparticles are crucial for effective drug delivery. In this study, to develop biostable nanoparticles with high tumor targetability, poly(ethylene glycol)-conjugated hyaluronic acid nanoparticles (PEG-HANPs) were mineralized through controlled deposition of inorganic calcium and phosphate ions on the nanoparticular shell via a sequential addition method. The resulting nanoparticles (M-PEG-HANPs) had a smaller size (153.7 +/- 4.5 nm) than bare PEG-HANPs (265.1 +/- 9.5 nm), implying that mineralization allows the formation of compact nanoparticles. Interestingly, when the mineralized nanoparticles were exposed to acidic buffer conditions (

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据